Firalis focuses on biomarkers related to inflammatory disorders, including common diseases like atherosclerosis and rheumatoid arthritis, as well as rare diseases. They also specialize in drug-induced organ injuries, particularly in the kidney, liver, and vasculature. With a unique network of clinical centers of excellence, Firalis conducts studies to qualify biomarkers in clinics. Their goal is to launch high-value diagnostic kits in the near future. The company is located in Huningue, near Basel, and is known for its expertise in cardiovascular biomarkers.